These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7142095)

  • 21. [A recent cephalosporin: cefadroxil. Clinical study and comparative blood levels after administration during fasting and after a meal].
    Di Stefano A; Gemme G
    Minerva Pediatr; 1981 Sep; 33(17):871-80. PubMed ID: 7311951
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of Cephadroxyl in urinary tract infections in adults].
    Bartolotta G; Siragusa A
    Minerva Urol; 1980; 32(1):45-8. PubMed ID: 7382967
    [No Abstract]   [Full Text] [Related]  

  • 23. A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of "Bad Bugs, Few Drugs".
    Nguyen HM; Graber CJ
    Int J Antimicrob Agents; 2020 Oct; 56(4):106085. PubMed ID: 32659466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of cephalexin two vs. three times daily vs. cefadroxil once daily for streptococcal tonsillopharyngitis.
    Curtin CD; Casey JR; Murray PC; Cleary CT; Hoeger WJ; Marsocci SM; Murphy ML; Francis AB; Pichichero ME
    Clin Pediatr (Phila); 2003; 42(6):519-26. PubMed ID: 12921453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic urinary tract infections with cephalexin (Ceporexine) orally administered at 12-hourly intervals.
    Nilsson LB
    Chemotherapy; 1976; 22(5):331-4. PubMed ID: 947712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies on cefadroxil in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Suzuki K; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Yamamoto M; Komatsu Y; Koga M; Ohta M; Tanaka M; Takasaki Y; Nagai T
    Jpn J Antibiot; 1983 Jan; 36(1):93-102. PubMed ID: 6842830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutical experience of cefadroxil against acute infectious diseases in the otorhinolaryngological field (author's transl)].
    Nagaba M
    Jpn J Antibiot; 1980 Mar; 33(3):253-5. PubMed ID: 7401306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and clinical studies with cefadroxil in paediatrics.
    Windorfer A; Bauer P
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():85-91. PubMed ID: 7142099
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical results of cefadroxil in pediatric field (author's transl)].
    Shinozaki T; Komaki K; Hashira S; Fujii R
    Jpn J Antibiot; 1981 Feb; 34(2):146-51. PubMed ID: 7253193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical experience of cefadroxil for respiratory infections (author's transl)].
    Kajiki A; Takamoto M; Ishibashi T
    Jpn J Antibiot; 1980 Dec; 33(12):1274-6. PubMed ID: 7241800
    [No Abstract]   [Full Text] [Related]  

  • 31. Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics.
    Ginsburg CM; McCracken GH
    J Pediatr; 1980 Feb; 96(2):340-2. PubMed ID: 7351610
    [No Abstract]   [Full Text] [Related]  

  • 32. Cephalexin compared with ampicillin in urinary tract infections in children.
    Elo J; Ahava K
    J Antimicrob Chemother; 1975; 1(3 Suppl):85-92. PubMed ID: 1104558
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of small doses of cephalexin (125 mg) in the management of recurrent urinary tract infection in women.
    Gower PE
    J Antimicrob Chemother; 1975; 1(3 Suppl):93-8. PubMed ID: 1104559
    [No Abstract]   [Full Text] [Related]  

  • 34. [A double blind comparative study of cefadroxil and cephalexin on scarlet fever].
    Tomizawa I; Takizawa Y; Konishi K; Imagawa Y; Murata M; Tsuji M; Matsubara Y; Seo T; Sagara H; Niwano K; Ohkubo N; Kashiwagi Y; Shibata M; Nagase K; Ogawa N; Nagai T
    Kansenshogaku Zasshi; 1982 Apr; 56(4):294-310. PubMed ID: 6813392
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
    Ballantyne FN
    Clin Ther; 1985; 7(4):487-91. PubMed ID: 4016827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefadroxil in the treatment of soft tissue infections.
    Ballantyne F
    J Int Med Res; 1980; 8(Suppl 1):64-9. PubMed ID: 7439508
    [No Abstract]   [Full Text] [Related]  

  • 37. Cefadroxil treatment of infections of the ears, nose and throat.
    Federspil P; Wilhelm HJ
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():115-9. PubMed ID: 7142088
    [No Abstract]   [Full Text] [Related]  

  • 38. [Fundamental and clinical studies on cefadroxil dry syrup in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1981 Jan; 34(1):33-40. PubMed ID: 7241805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women.
    Raz R; Rozenfeld S
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2200-1. PubMed ID: 8878607
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of cefadroxil and cephalexin in oral prophylaxis of postoperative sepsis.
    Sgarlato TE
    J Am Podiatry Assoc; 1984 Nov; 74(11):538-40. PubMed ID: 6501773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.